- Q1 2024 DURECT Corp Earnings Call TranscriptMay 13, 2024€0.95 (+1.60%)Earnings
- Q4 2023 DURECT Corp Earnings Call TranscriptMar 27, 2024€1.15 (+1.77%)Earnings
- Q3 2023 DURECT Corp Earnings Call TranscriptNov 13, 2023Earnings
- DURECT Corp Announces Topline Results from Phase 2b AHFIRM Trial of Larsucosterol TranscriptNov 07, 2023
- DURECT Corp at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 27, 2023
- Q2 2023 DURECT Corp Earnings Call TranscriptAug 09, 2023€2.82 (-0.70%)Earnings
- Q1 2023 DURECT Corp Earnings Call TranscriptMay 08, 2023€4.3 (+10.82%)Earnings
- DURECT Corp at H.C. Wainwright BioConnect Investor Conference TranscriptMay 02, 2023
- DURECT Corp at Oppenheimer Healthcare Conference (Virtual) TranscriptMar 15, 2023
- Q4 2022 DURECT Corp Earnings Call TranscriptMar 07, 2023€4.56 (+2.24%)Earnings
- Q3 2022 DURECT Corp Earnings Call TranscriptNov 02, 2022€6.15 (-1.60%)Earnings
- Q2 2022 DURECT Corp Earnings Call TranscriptAug 04, 2022€5.7 (+8.57%)Earnings
- DURECT Corp Annual Shareholders Meeting TranscriptJun 15, 2022
- Q1 2022 DURECT Corp Earnings Call TranscriptMay 04, 2022€4.06 (+2.01%)Earnings
- Q4 2021 DURECT Corp Earnings Call TranscriptMar 07, 2022€5.6 (-3.45%)Earnings
- DURECT Corp To Discuss Agreement Call TranscriptDec 22, 2021
- Q3 2021 DURECT Corp Earnings Call TranscriptNov 02, 2021€10.9Earnings
- DURECT Corp at H C Wainwright NASH Investor Conference (Virtual) TranscriptOct 12, 2021
- Q2 2021 DURECT Corp Earnings Call TranscriptJul 29, 2021€11.8 (+2.61%)Earnings
- DURECT Corp Annual Shareholders Meeting TranscriptJun 15, 2021
- Q1 2021 DURECT Corp Earnings Call TranscriptMay 04, 2021€15.6 (-1.27%)Earnings
- Q4 2020 DURECT Corp Earnings Call TranscriptMar 04, 2021€17.6 (-7.85%)Earnings
- DURECT Corporation - Special Call TranscriptFeb 02, 2021
- DURECT Corporation - Special Call TranscriptNov 20, 2020
- Q3 2020 DURECT Corp Earnings Call TranscriptNov 02, 2020€15.4 (-0.65%)Earnings
- DURECT Corporation - Special Call TranscriptAug 27, 2020
- DURECT Corp DURECT Corporation Summary TranscriptAug 06, 2020
- Q2 2020 DURECT Corp Earnings Call TranscriptAug 03, 2020€17.2 (-1.15%)Earnings
- DURECT Corp Annual Shareholders Meeting TranscriptJun 17, 2020
- Q1 2020 DURECT Corp Earnings Call TranscriptMay 11, 2020€21 (+8.81%)Earnings
- Q4 2019 DURECT Corp Earnings Call TranscriptMar 03, 2020€17.5 (+6.71%)Earnings
- DURECT Corporation - Special Call TranscriptNov 12, 2019
- Q3 2019 DURECT Corp Earnings Call TranscriptNov 04, 2019€17 (+4.94%)Earnings
- Q2 2019 DURECT Corp Earnings Call TranscriptAug 01, 2019€9.64 (+0.88%)Earnings
- Q1 2019 DURECT Corp Earnings Call TranscriptMay 08, 2019€6.56 (-4.29%)Earnings
- DURECT Corporation Key Opinion Leader Call on NASH TranscriptApr 17, 2019
- DURECT Corporation Key Opinion Leader Call on Psoriasis TranscriptMar 29, 2019
- Q4 2018 DURECT Corp Earnings Call TranscriptMar 07, 2019€6.3 (-6.25%)Earnings
- DURECT Corporation - Special Call TranscriptFeb 27, 2019
Q2 2019 DURECT Corp Earnings Call Transcript
Greetings and welcome to the DURECT's second quarter earnings conference call. (Operator Instructions)
As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Mike Arenberg, Chief Financial Officer. Please go ahead.
Good afternoon and welcome to our second quarter 2019 earnings conference call. This is Mike Arenberg, Chief Financial Officer of DURECT Corporation. I will provide a brief review of our financial results, and then Jim Brown, our President and CEO, will provide a business update. We will then open up the call for a question-and-answer session.
Before beginning, I would like to remind you of our safe harbor statement. During the course of this call, we may make forward-looking statements regarding DURECT's products and development, expected product benefits, our development plans, future clinical trials or projected financial results. These forward-looking statements involve risks and uncertainties that can cause actual results to differ
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)